Concepedia

POS0239 RISK OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AGED ≥50 YEARS WITH ≥1 CARDIOVASCULAR RISK FACTOR: RESULTS FROM A PHASE 3b/4 RANDOMISED STUDY OF TOFACITINIB VS TUMOUR NECROSIS FACTOR INHIBITORS

Christina Charles‐Schoeman, Roy Fleischmann, E. Mysler, M. Greenwald, C. Wang, A. S. Chen, C. A. Connell, J. Woolcott, S. Menon, Y. Chen,

Annals of the Rheumatic Diseases · 2022 · 16 citations · 0 references

DOIFull text

Open access

Concepts